Updated results of Transpher A: multicenter, single-dose, phase 1/2 clinical trial of ABO-102 for Sanfilippo syndrome type A (mucopolysaccharidosis IIIA)

被引：0
|
作者：
Flanigan, Kevin [1 ]
Smith, Nicholas [2 ]
Couce, Maria [3 ]
Escolar, Maria [4 ]
Truxal, Kristen [1 ]
McBride, Kim [1 ]
de Castro, Maria [3 ]
Fuller, Maria [2 ]
Paneda, Astrid [5 ]
Ruiz, Juan [5 ]
机构：
[1] Nationwide Childrens Hosp, Columbus, OH USA
[2] Womens & Childrens Hosp, Adelaide, SA, Australia
[3] Hosp Clin Univ Santiago de Compostela, Santiago De Compostela, Spain
[4] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA
[5] Abeona Therapeut, Dallas, TX USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2021年 / 132卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
eP203
引用
收藏
页码：S133 / S134
页数：3
相关论文
共 42 条
  • [1] Updated Results of Transpher A, a Multicenter, Single-Dose, Phase 1/2 Clinical Trial of ABO-102 Gene Therapy for Sanfilippo Syndrome Type A (Mucopolysaccharidosis IIIA)
    Flanigan, Kevin M.
    Smith, Nicholas J. C.
    Couce, Maria L.
    Escolar, Maria
    Truxal, Kristen V.
    McBride, Kim L.
    de Castro, Maria J.
    Fuller, Maria
    Paneda, Astrid
    Ruiz, Juan
    MOLECULAR THERAPY, 2021, 29 (04) : 104 - 105
  • [2] Updated results of Transpher A, a multicenter, single-dose, Phase 1/2 clinical trial of ABO-102 investigational gene therapy for Sanfilippo syndrome type A (mucopolysaccharidosis IIIA)
    Flanigan, K. M.
    Smith, N. J. C.
    Couce, M. L.
    Escolar, M.
    Truxal, K. V.
    McBride, K. L.
    de Castro, M. J.
    Fuller, M.
    Paneda, A.
    Ruiz, J.
    del Campo, A. B.
    Grachev, I. D.
    NEUROLOGY, 2022, 98 (18)
  • [3] Results of Transpher A, a Multicenter, Single-Dose, Phase 1/2 Clinical Trial of ABO-102 Gene Therapy for Sanfilippo Syndrome Type A (Mucopolysaccharidosis IIIA)
    Flanigan, K.
    Smith, N.
    Couce, M.
    Escolar, M.
    Truxal, K.
    McBride, K.
    de Castro, M.
    Fuller, M.
    Paneda, A.
    Ruiz, J.
    ANNALS OF NEUROLOGY, 2021, 90 : S85 - S85
  • [4] Updated Interim Results of Transpher A, a Multicenter, Single-Dose, Pivotal Clinical Trial of ABO-102 Gene Therapy for Sanfilippo Syndrome Type A (Mucopolysaccharidosis IIIA)
    Flanigan, K. M.
    Smith, N. J. C.
    Couce, M. L.
    Rajan, D. S.
    Truxal, K. V.
    McBride, K. L.
    de Castro, M. J.
    Fuller, M.
    Taylor, J.
    del Campo, A. B.
    Grachev, I. D.
    MOLECULAR THERAPY, 2022, 30 (04) : 221 - 221
  • [5] Interim results of Transpher A, a multicenter, single-dose, phase 1/2 clinical trial of ABO-102 gene therapy for Sanfilippo syndrome type A (mucopolysaccharidosis type IIIA)
    Flanigan, Kevin M.
    Smith, Nicholas J. C.
    Luz Couce, Maria
    Truxal, Kristen V.
    McBride, Kim L.
    Simmons, Tabatha
    Jose de Castro, Maria
    Cope, Krista
    Teresa Oreiro, Maria
    Jaensch, Louise
    Fuller, Maria
    Ruiz, Juan
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S56 - S57
  • [6] Interim results of Transpher A, a multicentre, single-dose, phase 1/2 clinical trial of ABO-102 investigational gene therapy for Sanfilippo syndrome type A (mucopolysaccharidosis IIIA)
    Flanigan, Kevin M.
    Smith, Nicholas J. N.
    Couce, Maria L.
    Escolar, Maria
    Truxal, Kristen V.
    McBride, Kim L.
    de Castro, Maria J.
    Fuller, Maria
    Paneda, A.
    Ruiz, J.
    del Campo, A. B.
    Grachev, I.
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S43 - S43
  • [7] Transpher A, a multicenter, single-dose, phase 1/2 clinical trial of ABO-102, an intravenous AAV9-based gene therapy for Sanfilippo Syndrome Type A (Mucopolysaccharidosis IIIA)
    Flanigan, K. M.
    Smith, N. J. C.
    Couce, M. L.
    Truxal, K. V.
    McBride, K. L.
    Simmons, T. R.
    de Castro, M. J.
    Cope, K. L.
    Oreiro, M. T.
    Jaensch, L.
    Fuller, M.
    Ruiz, J.
    NEUROLOGY, 2020, 94 (15)
  • [8] Safety, tolerability, biopotency and neurocognitive data of ABO-102 in Transpher A, an open-label, multicenter, single-dose, dose-escalation, Phase 1/2 Clinical Trial in Sanfilippo Syndrome type A (Mucopolysaccharidosis IIIA
    de Castro, M. J.
    Flanigan, K. M.
    Smith, N. J. C.
    Couce, M. L.
    Truxal, K. V.
    McBride, K. L.
    Simmons, T. R.
    McNally, K. A.
    Oreiro, M. T.
    Kunkler, K. L.
    Jaensch, L.
    Fuller, M.
    Ruiz, J.
    HUMAN GENE THERAPY, 2019, 30 (11) : A15 - A15
  • [9] Updated results of Transpher B: multicenter, single-dose, phase 1/2 clinical trial of ABO-101 for Sanfilippo syndrome type B (mucopolysaccharidosis IIIB)
    de Castro, Maria
    Flanigan, Kevin
    Heron, Benedicte
    Muschol, Nicole
    Couce, Maria
    Truxal, Kristen
    McBride, Kim
    Ravelli, Claudia
    Ammer, Luise
    Lindschau, Mona
    Fuller, Maria
    del Campo, Ana
    Ruiz, Juan
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 : S139 - S139
  • [10] Transpher A, an Open-Label, Multicenter, Single-Dose, Dose-Escalation, Phase 1/2 Clinical Trial of Gene Transfer of ABO-102 in Sanfilippo Syndrome Type A (Mucopolysaccharidosis IIIA): Safety, Tolerability, Biopotency and Neurocognitive Data
    Flanigan, Kevin
    Smith, Nicholas J. C.
    Luz Couce, Maria
    Truxal, Kristen V.
    McBride, Kim L.
    Jose de Castro, Maria
    McNally, Kelly A.
    Simmons, Tabatha R.
    Cope, Krista L.
    Pertini, Mark
    Jaensch, Louise
    Lopez, Luisa
    Tajes, Maria
    Oreiro, Maria T.
    Chans, Roi
    Fuller, Maria
    Paneda, Astrid
    Ruiz, Juan
    MOLECULAR THERAPY, 2020, 28 (04) : 231 - 231
12345